热门科学

CAR-T

论题描述： This hub is created to discuss CAR-T cell therapy for cancer treatment such as leukemia, large B cell lymphoma.

热门最新活跃 Reviewer Roulette

置顶内容上次更新 2年前

CAR-T therapies are progressing to the market at a much faster rate. Novartis just received approval from Australian authorities to make it's CAR-T therapy available to all eligible patients. Additionally, Bristol-Myers Squibb also received FDA approval in the US for it's CAR-T cell therapy for adults with relapsed large B-cell lymphoma. Kite Pharma already has FDA approved CAR-T cell therapy for the same in the market for a while now. Seems like all major Pharma/Biotech companies will soon embrace CAR-T's, leading to more competition and hopefully making these therapies more affordable as a result. Below is a link to the latest advancements in CAR-T's by biopharma reporter.

链接: https://www.biopharma-reporter.com/Article/2021/02/15/Scientific-breakthroughs-approvals-Latest-CAR-T-cell-therapy-related-developments#:~:text=Earlier%20this%20month%2C%20the%20US,directed%20CAR%20T%2Dcell%20immunotherapy.

动态留言
归档留言 1

归档留言版	归档日期	讨论数
CAR-T's discussion		12

归档留言版	归档日期	讨论数
CAR-T's discussion		12

4 个成员: 创建者

Harwinder

Patrick

Neil

Wai

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

置顶内容 上次更新 2年前

Find the ideal target journal for your manuscript

Ask a Question. Answer a Question.

置顶内容上次更新 2年前